Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 8,263,554

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,263,554
Title:Methods of using GLP-1 receptor agonists to treat pancreatitis
Abstract: The disclosure provides the use of GLP-1 receptor agonist compounds to treat pancreatitis (e.g., acute, chronic, hemorrhagic, necrotizing) in patients. The disclosure also provides the use of GLP-1 receptor agonist compounds to reduce elevated plasma amylase and/or lipase concentrations in patients. An exemplary GLP-1 receptor agonist compound is exenatide.
Inventor(s): Tatarkiewicz; Krystyna (San Diego, CA), Parkes; David G. (Del Mar, CA), Roy; Denis (Vista, CA), Gedulin; Bronislava (Del Mar, CA)
Assignee: Amylin Pharmaceuticals, Inc. (San Diego, CA)
Application Number:13/155,211
Patent Claims:see list of patent claims

Details for Patent 8,263,554

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Glaxosmithkline Llc TANZEUM albiglutide For Injection 125431 2014-04-15 ⤷  Try it Free 2030-06-09
Eli Lilly And Company TRULICITY dulaglutide Injection 125469 2014-09-18 ⤷  Try it Free 2030-06-09
Eli Lilly And Company TRULICITY dulaglutide Injection 125469 2020-09-04 ⤷  Try it Free 2030-06-09
Sanofi-aventis U.s. Llc ADLYXIN lixisenatide Injection 208471 2016-07-27 ⤷  Try it Free 2030-06-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.